| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.08 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.08 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.074 | 0.08 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.08 |
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | 0.35 | 0.08 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.08 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.064 | 0.08 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.08 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.08 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.071 | 0.08 |